Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial

ObjectiveType 1 diabetes (T1D) is characterised by islet autoimmunity and beta cell destruction. A gut microbiota–immunological interplay is involved in the pathophysiology of T1D. We studied microbiota-mediated effects on disease progression in patients with type 1 diabetes using faecal microbiota...

Full description

Saved in:
Bibliographic Details
Published inGut Vol. 70; no. 1; pp. 92 - 105
Main Authors de Groot, Pieter, Nikolic, Tanja, Pellegrini, Silvia, Sordi, Valeria, Imangaliyev, Sultan, Rampanelli, Elena, Hanssen, Nordin, Attaye, Ilias, Bakker, Guido, Duinkerken, Gaby, Joosten, Antoinette, Prodan, Andrei, Levin, Evgeni, Levels, Han, Potter van Loon, Bartjan, van Bon, Arianne, Brouwer, Catherina, van Dam, Sytze, Simsek, Suat, van Raalte, Daniel, Stam, Frank, Gerdes, Victor, Hoogma, Roel, Diekman, Martin, Gerding, Martin, Rustemeijer, Cees, de Bakker, Bernadette, Hoekstra, Joost, Zwinderman, Aeilko, Bergman, Jacques, Holleman, Frits, Piemonti, Lorenzo, De Vos, Willem, Roep, Bart, Nieuwdorp, Max
Format Journal Article
LanguageEnglish
Published England BMJ Publishing Group Ltd and British Society of Gastroenterology 01.01.2021
BMJ Publishing Group LTD
BMJ Publishing Group
SeriesOriginal research
Subjects
Online AccessGet full text

Cover

Loading…